Oncovirus cancerous agent
[email protected] or
[email protected]
the
Table of contents 1. 2. 3. 4. 5. 6. 7. 8.
Definition History Classification Key words Transformation Oncogene Replication Example– DNA Oncovirus (HPV) RNA Oncovirus (HTLV)
Defination: *viral agents causing cancer in eukaryotic animals by integrating in host genome *A virus associated with malignancies in natural host, experimental animals or cell cultures. *viruses which modified proto-oncogene, obligatory host specific, with the ability immortalization, possess genes which stimulate growth and cause cancer.
Research History In 1908, Ellerman & Bang first discovered virus, producing leukemia in chicken. In 1911 Peyton Rous 1st shows the presence of filterable sarcoma material that induce the CANCER.
Classification Oncovirus
DNA oncogenic viruses
RNA oncogenic viruses
DNA Oncov iruses Virus Family
Papovaviridae
Herpesviridae
Virus
Associated tumours
Papilloma *
Genital (Cervical, vulvar, penile) warts, may progress to .carcinoma
Polyoma *
Various carcinomas and sarcomas
SV40
( Sarcoma(in Rodents
BK & JC *
Polyoma in man, tumours in rodents
( Hepatitis simplex type (1 & 2
•
Cervical carcinoma
Cytomegalovirus *
Koposo's sarcoma, cervical neoplasia
Epstein Barr virus *
,Nasopharyngeal carcinoma Burkitt's lymphoma, B Cell lymphoma
Hepatitis viruses
Hepatitis B viruses *
Primary hepatocelular carcinoma
Pox virus
Molluscum
Nodular epidermal hyperplasia
Adenoviridae
contagiosum *
Shope fibroma *
Fibroma
Yabavirus
Nodular fibromatous hyperplasia
Type 2, 5, 12
None in man, sarcomas in hemsters
RN A Oncovir use s Retroviridae Avian sarcoma leucosis virus (ALV) complex
Various sarcomas, lymphomas and .lekaemia (natural tumours) in birds
Mouse leukaemia and (sercoma (MLV
. Various sarcomas, leukaemias
(Feline leukaemis (Fel V
Various sarcomas, lymphomas in mice and lekaemias
Bovine leukaemia
Lymphosarcoma (B cells) in cattle
Human T Cell leukaemia * ((HTLA-1, 2
T-cell leukaemis/lymphoma in man
Flaviridae Hepatitis C virus *
Primary hepatocellular carcinoma
Oncogenic Viruses associated with human cancer Virus family
virus
Type of malignancy
DNA VIRUS Papovaviridae
Herpesviridae
Human papilloma virus
Cervical, Valvular, Penile cancers of squamous cell type polyma
BK virus and JC virus
Polyoma
EB virus
Burkitt's lymphoma, cervical carcinoma
HSP type 2
B-Cell lymphoma, Cevical carcinoma
Hepatitis C virus
Hepatocellular carcinoma
HTLV
Adult T-Cell leukaemia
RNA VIRUS Flaviridae Retroviridae
Key Words Immortalization : ability of virus to establish persistent
infection that can also stimulate uncontrolled cell growth indefinitely provided that adequate nutrients are available. Neoplasia: property of cell to undergo rapid, abnormal and uncontrolled growth at the cost of remaining cells.
Permissive and Non-permissive cell Malignancy HeLa cell Episomes Transformation: Ability of virus infected cell, to Change in the biological functions of a cell by the regulation of viral genes to cause malignant growth result in NEOPLASIA. these change often (but not always) result from integration of the viral genome into host cell genome.
Transformation of Normal cell to cancer cell
Characteristics of Transformed cells: ► Possession
of viral genome: ► Morphologic changes: ► Loss of cell-contact inhibition of growth: ► Increased efficiency of clone formation ► Decreased growth factor requirements: ► Change in membrane transport properties: ► Expression of tumour-associated antigen: ► Change in plasma membrane composition: ► Chromosomal alteration:
Oncogene ► ► ► ► 5. 6. 7.
gene which encode for protein were first discovered in retroviruses proto-oncogenes exist naturally in the human genome Functions:INDUCTION OF CELLULAR PROLIFERATION INHIBITION OF CELLULAR PROLIFERATION REGULATION OF PROGRAMMED CELL DEATH
Type of Oncoviral infection 1. Productive : Synthesis and Release of progeny virus. a) Lytic—Host cell Killed e.g. DNA virus b) Nonlytic—No noticeable cytopatic effect on host cell e.g.. RNA virus 2. Non Productive : Progeny virus nor produced a) Abortive—loss of viral genome after infection b) Defective—viral genome incomplete c) Non permissive—Host cell lack certain factor
Multiplication of oncoviruses ► DNA
Oncovirus:
► RNA
Oncovirus:
In case of oncogenic DNA viruses: ► integrated with the host cell genome as prophage ► encoded proteins which bind and inactivate the growth-regulatory proteins of the cell ► such as the retinoblastoma (RB) or p53 gene product ► cells bcl-2 oncogene prevents (apoptosis). ► defective or incomplete, no infections virus is produced
Multiplication of a RNA oncovirus Capsid Reverse transcriptase
Envelope Two identical strands of RNA
Virus
1 Retrovirus penetrates host cell.
Host cell
DNA of one of the host cell’s chromosomes
5 Mature
retrovirus leaves host cell, acquiring an envelope as it buds out.
Identical strands of RNA Viral proteins RNA
Reverse transcriptase Viral RNA
4 Transcription of the
provirus may also occur, producing RNA for new retrovirus genomes and RNA that codes for the retrovirus capsid and envelope proteins.
Provirus
2
Its RNA is uncoated; reverse transcription takes place.
3 The new viral DNA is
tranported into the host cell’s nucleus and integrated as a provirus. The provirus may divide indefinitely with the host cell DNA. Figure 13.19
► Examples
CLASSIFICATION ► Phylum:
Vira ► Sub Phylum: Deoxyvira ► Class: Deoxycubica ► Order: Haplovirales ► Group: Group I (dsDNA) ► Family: Papovaviridae ► Genus: Papillomavirus ► Strain : Human papillomavirus
► Papillomaviruses
are a diverse group of DNA-based viruses that infect the skin and mucous membranes of humans and a variety of animals
► Richard
Shope
TYPES ► More
than 100 types of human papilloma viruses (HPVs) ► HPVs 16, 18, 31, 33, 35, 39, 45, 50, 51,53, 55, 56, 58, 59, 64 and 68 are considered “high risk” types ► HPV 16 and 18 are the most closely associated with cervical carcinoma
► Some
sexually transmitted HPVs -- types 6, 11, may cause genital warts
Structure ► small ► non-enveloped ► (~52-55nm
diameter ) ► A single viral protein (L1 ) necessary and sufficient for formation of a 60 nm capsid composed of 72 star-shaped
GENOME
GENE ORGANIZATION ► typically
contains around 8000 bp [7904 bp forHPV16 (GenBank® accession number NC 001526)] ► organized in three regions: • the early gene (E1 to E7) • the late gene (L1 and L2) • the upper regulatory region (URR)
► E1
: encode proteins that are vital for extra chromosomal DNA replication and the completion of the viral life cycle ► E2 : encodes two proteins - one, which inhibits transcription of the early region; and the other, which increases the transcription of the early region ► E4 : Maturation, induces the collapse of the cytoplasmic cytokeratin network in human keratinocytes, stimulate releasing ►
► E5
: interacts with various transmembrane proteins like the receptors of the epidermal growth factor, platelet-derived growth factor, and colony stimulating factor-1 ► E6 and E7 :encode for oncoproteins that allow replication of the virus and the immortalization and transformation of the cell that hosts the HPV DNA. ► L1 and L2 : encode for viral capsid proteins during the late stages of virion assembly
Regulation Mechanism ► E7
associates with pRb and disrupts the association between pRb and the E2F ► .E7 also associates with histone deacetylases, components of the AP1 transcription complex and the cyclindependent kinase inhibitors p21 and p27. ► in the high-risk HPV types, both E6 and E7 proteins are expressed together from a single polycistronic mRNA species.
► E7
block ARF (ADPribosylation factor) pathway ► E6 PDZbinding can mediate suprabasal cell proliferation and may contribute to the development of metastatic tumours by disrupting normal cell adhesion
Transmission ► By
skin-to-skin or mucosa-to-mucosa contact ► By sexual contact ► By mother to child during birth
Major steps in the development of
HOW IT GIVES THE SYMPTOMS OF CANCER
► “low
risk” HPV gives warts on the anus, vagina, vulva, penis and thighs. ► “intermediate risk” give lesion. ► “high risk” gives pre-cancerous lesions and can lead to cancer of the cervix, anus and other genital areas.
DIAGNOSIS 1) Pap (Papanicolou) test : to detect celular change. *cells collected from the cervix (the lower, narrow end of the uterus) to detect cancer or abnormal cells that may lead to cancer 2) Colloscopy : 3) DNA test :
Prevention • • • •
Absolutely no skin-to-skin sexual contact The more sexual partners, the higher the chance of contracting HPV. contraception Vaccination is now available to prevent certain low risk types that cause genital warts certain high risk types that cause cancer.
Treatment ► Cryotherapy
– liq. N2 ► Cautery – electrical current, laser therapy ► Chemical treatments - drugs ► Surgery – removal ► Vaccination
Production of prophylactic HPV virus-like particle (VLP) vaccines The vaccine mimics the virus shell
(Atomic force microscopy image of a single VLP)
L1 capsomere L1
L1 protein
5 x L1
Virus-Like Particle (VLP)
72 capsomeres
Atomic force microscopy image of a single VLP
5 x L1
L1-external protein
Expression and self assembly in a recombinant eukaryotic vector
Adapted from Syrjänen & Syrjänen. Papillomavirus infections in human pathology. Wiley & Sons, Chichester; 2000. pp 11–46.
HPV 16 VLP composed of 72 capsomere subunits of L1 protein
Major Pharma developing HPV VLP vaccines Sanofi Pasteur MSD - Gardasil a quadrivalent HPV 6, 11, 16, 18 L1 VLP vaccine; alum adjuvanted licensed in UK October 2006 awaiting guidance from Joint Committee on Vaccination and Immunisation (JCVI) regarding policy for vaccination in the UK GlaxoSmithKline - Cervarix a bivalent HPV 16, 18 L1 VLP vaccine; AS04 adjuvanted submitted to European Agency for the Evaluation of Medicines (EMEA) March 2006
BREIF DISCRIPTION OF RNA VIRUS ► RNA
oncovirus also calles as oncornaviruses.
Classification ► Phylum:
Vira ► Sub Phylum: Ribovira ► Class: Ribocubica ► Order: Gymnovirales ► Group: RNA ► Family: Retroviridae ► Subfamily:
Orthoretrovirinae ► Genus: Deltaretrovirus ► Strain
: Human T-cell leukemia virus ► Type : HTLV 1 & 2
► Infection
in T-cells ► Transmission ► Gives Adult T-cell leukemia (ATL) ► Composed of 2 copies of ssRNA
References
► www.wikipedia.com ► www.iarc.uk
► www.cancerresearchuk.org ► www.cancer.gov ► https://cissecure.nci.nih.gov/
www.nature.com ► Research paper by john Doorbar ► www.hpvinfo.com ► Online Microbiology and immunology books ►
►
Research paper By Brandon Stott and Michelle Wyse
► http://www.jem.org/cgi/
CONCLUSION
DISCUSSION
THANK YOU